HEALTHCARE TRIANGLE INC (HCTI)
US42227W2070 - Common Stock
HCTI gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 40 industry peers in the Health Care Technology industry. HCTI has a bad profitability rating. Also its financial health evaluation is rather negative. HCTI has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year HCTI has reported negative net income.
HCTI had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HCTI reported negative net income in multiple years.
HCTI had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of -122.82%, HCTI is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
HCTI's Return On Equity of -2294.05% is on the low side compared to the rest of the industry. HCTI is outperformed by 87.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -122.82% | ||
| ROE | -2294.05% | ||
| ROIC | N/A |
ROA(3y)-64.42%
ROA(5y)-31.58%
ROE(3y)-802.65%
ROE(5y)-458.86%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of HCTI (20.42%) is worse than 92.31% of its industry peers.
In the last couple of years the Gross Margin of HCTI has declined.
The Profit Margin and Operating Margin are not available for HCTI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.42% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.36%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HCTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
HCTI has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, HCTI has a worse debt to assets ratio.
2.2 Solvency
HCTI has an Altman-Z score of -3.78. This is a bad value and indicates that HCTI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of HCTI (-3.78) is worse than 69.23% of its industry peers.
HCTI has a Debt/Equity ratio of 8.02. This is a high value indicating a heavy dependency on external financing.
HCTI has a Debt to Equity ratio of 8.02. This is amonst the worse of the industry: HCTI underperforms 87.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 8.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.78 |
ROIC/WACCN/A
WACC16.34%
2.3 Liquidity
A Current Ratio of 0.71 indicates that HCTI may have some problems paying its short term obligations.
HCTI has a Current ratio of 0.71. This is in the lower half of the industry: HCTI underperforms 79.49% of its industry peers.
A Quick Ratio of 0.71 indicates that HCTI may have some problems paying its short term obligations.
With a Quick ratio value of 0.71, HCTI is not doing good in the industry: 79.49% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.71 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
HCTI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.64%.
The Revenue for HCTI has decreased by -27.63% in the past year. This is quite bad
Measured over the past years, HCTI shows a small growth in Revenue. The Revenue has been growing by 1.94% on average per year.
EPS 1Y (TTM)-13.64%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-0.84%
Revenue 1Y (TTM)-27.63%
Revenue growth 3Y1.94%
Revenue growth 5YN/A
Revenue growth Q2Q-37.47%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.66%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
HCTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HCTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
HCTI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HEALTHCARE TRIANGLE INC
NASDAQ:HCTI (5/3/2024, 7:00:01 PM)
After market: 1.36 -0.01 (-0.73%)1.37
+0.14 (+11.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.37M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -122.82% | ||
| ROE | -2294.05% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.42% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover3.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 8.02 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.71 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-13.64%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-27.63%
Revenue growth 3Y1.94%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y